GPR182生物学功能与临床转化应用的研究 进展
Research Progress on the Biological Functions and Clinical Translational Applications of GPR182
DOI: 10.12677/acm.2026.162629, PDF,    科研立项经费支持
作者: 任远嘉:湖州师范学院医学院(护理学院),浙江 湖州;贺 颖:湖州师范学院附属第一人民医院中心实验室,浙江 湖州;姚林华:湖州师范学院附属第一人民医院消化内科,浙江 湖州
关键词: G蛋白偶联受体182β-Arrestin非典型趋化因子受体G蛋白偶联受体G蛋白偶联受体激酶G Protein-Coupled Receptor 182 β-Arrestin Atypical Chemokine Receptor G Protein-Coupled Receptor G Protein-Coupled Receptor Kinase
摘要: G蛋白偶联受体(G protein-coupled receptor, GPCR)家族是人体中数量最庞大的膜蛋白家族,在调控多种生理病理过程中发挥重要作用,也是重要的药物靶点类别。G蛋白偶联受体182 (G protein-coupled receptor 182, GPR182)作为一种新型非典型趋化因子受体(atypical chemokine receptor, ACKR),主要表达于血管内皮细胞、肝脏窦状内皮细胞等,通过糖胺聚糖(glycosaminoglycan, GAG)结合基序识别并结合趋化因子,依赖β-arrestin (β-抑制蛋白)和G蛋白偶联受体激酶(g protein-coupled receptor kinase, GRK)的协同作用,参与配体的结合与清除;通过与C-X-C趋化因子受体4 (C-X-C chemokine receptor 4, CXCR4)竞争性结合C-X-C趋化因子配体12 (C-X-C chemokine motif ligand 12, CXCL12)调控CXCL12-CXCR4轴信号传导。生理状态下,GPR182可以在血管生成中发挥负向调控作用,参与胚胎血管发育与造血稳态维持;病理状态下,GPR182在肝细胞癌中的表达水平显著下降,且与患者预后相关。本文重点围绕GPR182的生物学功能及信号传导机制展开详细论述,探讨了GPR182的临床转化前景,为GPR182的相关基础研究和临床转化应用提供精确参考。
Abstract: G protein-coupled receptors (GPCRs) constitute the largest family of membrane proteins in the human body, playing crucial roles in regulating a variety of physiological and pathological processes, and are also an important class of drug targets. G protein-coupled receptor 182 (GPR182), a novel atypical chemokine receptor (ACKR), is mainly expressed in vascular endothelial cells, hepatic sinusoidal endothelial cells, etc. It recognizes and binds chemokines through its glycosaminoglycan (GAG)-binding motif, and participates in ligand binding and clearance depending on the synergistic effect of β-arrestin and G protein-coupled receptor kinase (GRK). Additionally, GPR182 regulates the signaling of the C-X-C chemokine motif ligand 12 (CXCL12)-C-X-C chemokine receptor 4 (CXCR4) axis by competitively binding to CXCL12 with CXCR4. Under physiological conditions, GPR182 exerts a negative regulatory role in angiogenesis and is involved in embryonic vascular development and the maintenance of hematopoietic homeostasis. Under pathological conditions, its expression is significantly downregulated in hepatocellular carcinoma (HCC) and is associated with patient prognosis. This review focuses on the detailed discussion of the biological functions and signaling mechanisms of GPR182, explores its clinical translational prospects, and provides an accurate reference for basic research and clinical translational applications related to GPR182.
文章引用:任远嘉, 贺颖, 姚林华. GPR182生物学功能与临床转化应用的研究 进展[J]. 临床医学进展, 2026, 16(2): 2280-2287. https://doi.org/10.12677/acm.2026.162629

参考文献

[1] Lin, H. (2025) An Alternative Mode of GPCR Transactivation: Activation of GPCRs by Adhesion GPCRs. International Journal of Molecular Sciences, 26, Article 552. [Google Scholar] [CrossRef] [PubMed]
[2] Liu, S., Anderson, P.J., Rajagopal, S., Lefkowitz, R.J. and Rockman, H.A. (2024) G Protein-Coupled Receptors: A Century of Research and Discovery. Circulation Research, 135, 174-197. [Google Scholar] [CrossRef] [PubMed]
[3] Krumm, B.E. and Roth, B.L. (2025) Intracellular GPCR Modulators Enable Precision Pharmacology. npj Drug Discovery, 2, Article No. 8. [Google Scholar] [CrossRef] [PubMed]
[4] Lorente, J.S., Sokolov, A.V., Ferguson, G., Schiöth, H.B., Hauser, A.S. and Gloriam, D.E. (2025) GPCR Drug Discovery: New Agents, Targets and Indications. Nature Reviews Drug Discovery, 24, 458-479. [Google Scholar] [CrossRef] [PubMed]
[5] Wacker, D., Stevens, R.C. and Roth, B.L. (2017) How Ligands Illuminate GPCR Molecular Pharmacology. Cell, 170, 414-427. [Google Scholar] [CrossRef] [PubMed]
[6] Chevigné, A., Legler, D.F., Rot, A., Sozzani, S., Szpakowska, M. and Thelen, M. (2025) International Union of Basic and Clinical Pharmacology. CXVIII. Update on the Nomenclature for Atypical Chemokine Receptors, Including ACKR5. Pharmacological Reviews, 77, Article ID: 100012. [Google Scholar] [CrossRef] [PubMed]
[7] Comerford, I. and McColl, S.R. (2024) Atypical Chemokine Receptors in the Immune System. Nature Reviews Immunology, 24, 753-769. [Google Scholar] [CrossRef] [PubMed]
[8] Samus, M. and Rot, A. (2024) Atypical Chemokine Receptors in Cancer. Cytokine, 176, Article ID: 156504. [Google Scholar] [CrossRef] [PubMed]
[9] Torphy, R.J., Yee, E.J., Schulick, R.D. and Zhu, Y. (2022) Atypical Chemokine Receptors: Emerging Therapeutic Targets in Cancer. Trends in Pharmacological Sciences, 43, 1085-1097. [Google Scholar] [CrossRef] [PubMed]
[10] Lindsay, H.G., Hendrix, C.J., Gonzalez Murcia, J.D., Haynie, C. and Weber, K.S. (2023) The Role of Atypical Chemokine Receptors in Neuroinflammation and Neurodegenerative Disorders. International Journal of Molecular Sciences, 24, Article 16493. [Google Scholar] [CrossRef] [PubMed]
[11] Szpakowska, M., D’Uonnolo, G., Luís, R., Alonso Bartolomé, A., Thelen, M., Legler, D.F., et al. (2023) New Pairings and Deorphanization among the Atypical Chemokine Receptor Family—Physiological and Clinical Relevance. Frontiers in Immunology, 14, Article 1133394. [Google Scholar] [CrossRef] [PubMed]
[12] Joost, P. and Methner, A. (2002) Phylogenetic Analysis of 277 Human G-Protein-Coupled Receptors as a Tool for the Prediction of Orphan Receptor Ligands. Genome Biology, 3, Article No. research0063.1. [Google Scholar] [CrossRef] [PubMed]
[13] Kapas, S., Catt, K.J. and Clark, A.J.L. (1995) Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor. Journal of Biological Chemistry, 270, 25344-25347. [Google Scholar] [CrossRef] [PubMed]
[14] Kennedy, S.P., Sun, D., Oleynek, J.J., Hoth, C.F., Kong, J. and Hill, R.J. (1998) Expression of the Rat Adrenomedullin Receptor or a Putative Human Adrenomedullin Receptor Does Not Correlate with Adrenomedullin Binding or Functional Response. Biochemical and Biophysical Research Communications, 244, 832-837. [Google Scholar] [CrossRef] [PubMed]
[15] Melgrati, S., Gerken, O.J., Artinger, M., Radice, E., Szpakowska, M., Chevigné, A., et al. (2023) GPR182 Is a Broadly Scavenging Atypical Chemokine Receptor Influencing T-Independent Immunity. Frontiers in Immunology, 14, Article 1242531. [Google Scholar] [CrossRef] [PubMed]
[16] Hänze, J., Dittrich, K., Dötsch, J. and Rascher, W. (1997) Molecular Cloning of a Novel Human Receptor Gene with Homology to the Rat Adrenomedullin Receptor and High Expression in Heart and Immune System. Biochemical and Biophysical Research Communications, 240, 183-188. [Google Scholar] [CrossRef] [PubMed]
[17] Sumanas, S., Jorniak, T. and Lin, S. (2005) Identification of Novel Vascular Endothelial-Specific Genes by the Microarray Analysis of the Zebrafish Cloche Mutants. Blood, 106, 534-541. [Google Scholar] [CrossRef] [PubMed]
[18] Takase, H., Matsumoto, K., Yamadera, R., Kubota, Y., Otsu, A., Suzuki, R., et al. (2012) Genome-Wide Identification of Endothelial Cell-Enriched Genes in the Mouse Embryo. Blood, 120, 914-923. [Google Scholar] [CrossRef] [PubMed]
[19] Schmid, C.D., Schledzewski, K., Mogler, C., Waldburger, N., Kalna, V., Marx, A., et al. (2018) GPR182 Is a Novel Marker for Sinusoidal Endothelial Differentiation with Distinct GPCR Signaling Activity in Vitro. Biochemical and Biophysical Research Communications, 497, 32-38. [Google Scholar] [CrossRef] [PubMed]
[20] Kechele, D.O., Blue, R.E., Zwarycz, B., Espenschied, S.T., Mah, A.T., Siegel, M.B., et al. (2017) Orphan GPR182 Suppresses ERK-Mediated Intestinal Proliferation during Regeneration and Adenoma Formation. Journal of Clinical Investigation, 127, 593-607. [Google Scholar] [CrossRef] [PubMed]
[21] Chen, C., Liu, W., Yuan, F., Wang, X., Xu, X., Ling, C.C., et al. (2025) G Protein-Coupled Receptor GPR182 Negatively Regulates Sprouting Angiogenesis via Modulating CXCL12-CXCR4 Axis Signaling. Angiogenesis, 28, Article No. 25. [Google Scholar] [CrossRef] [PubMed]
[22] Torphy, R.J., Sun, Y., Lin, R., Caffrey-Carr, A., Fujiwara, Y., Ho, F., et al. (2022) GPR182 Limits Antitumor Immunity via Chemokine Scavenging in Mouse Melanoma Models. Nature Communications, 13, Article No. 97. [Google Scholar] [CrossRef] [PubMed]
[23] Ghilardi, C., Chiorino, G., Dossi, R., Nagy, Z., Giavazzi, R. and Bani, M. (2008) Identification of Novel Vascular Markers through Gene Expression Profiling of Tumor-Derived Endothelium. BMC Genomics, 9, Article No. 201. [Google Scholar] [CrossRef] [PubMed]
[24] Xiao, L., Harrell, J.C., Perou, C.M. and Dudley, A.C. (2013) Identification of a Stable Molecular Signature in Mammary Tumor Endothelial Cells That Persists in Vitro. Angiogenesis, 17, 511-518. [Google Scholar] [CrossRef] [PubMed]
[25] Kwon, H., Mackie, D.I., Bonnavion, R., Mercier, A.L., Helker, C.S.M., Son, T., et al. (2020) The Orphan G-Protein Coupled Receptor 182 Is a Negative Regulator of Definitive Hematopoiesis through Leukotriene B4 Signaling. ACS Pharmacology & Translational Science, 3, 676-689. [Google Scholar] [CrossRef] [PubMed]
[26] Yang, Y., Li, J., Lei, W., Wang, H., Ni, Y., Liu, Y., et al. (2023) CXCL12-CXCR4/CXCR7 Axis in Cancer: From Mechanisms to Clinical Applications. International Journal of Biological Sciences, 19, 3341-3359. [Google Scholar] [CrossRef] [PubMed]
[27] Bachelerie, F., Graham, G.J., Locati, M., Mantovani, A., Murphy, P.M., Nibbs, R., et al. (2015) An Atypical Addition to the Chemokine Receptor Nomenclature: IUPHAR Review 15. British Journal of Pharmacology, 172, 3945-3949. [Google Scholar] [CrossRef] [PubMed]
[28] Montpas, N., St-Onge, G., Nama, N., Rhainds, D., Benredjem, B., Girard, M., et al. (2018) Ligand-Specific Conformational Transitions and Intracellular Transport Are Required for Atypical Chemokine Receptor 3-Mediated Chemokine Scavenging. Journal of Biological Chemistry, 293, 893-905. [Google Scholar] [CrossRef] [PubMed]
[29] Le Mercier, A., Bonnavion, R., Yu, W., Alnouri, M.W., Ramas, S., Zhang, Y., et al. (2021) GPR182 Is an Endothelium-Specific Atypical Chemokine Receptor That Maintains Hematopoietic Stem Cell Homeostasis. Proceedings of the National Academy of Sciences of the United States of America, 118, e2021596118. [Google Scholar] [CrossRef] [PubMed]